High Costs Of Cancer Drugs May Harm Patients, Say Experts

Medscape: High Price Of Cancer Drugs Is Harming Patients
The extremely high prices of recent cancer drugs "may be causing harm to patients," a large group of international leukemia experts warns. In a forum article published online April 25 in Blood, the group of 120 experts from around the world discuss the high cost of leukemia drugs, but emphasize that their concerns extend to many other types of cancer drugs. The high price of drugs has resulted in nonadherence to treatment, they note. In the United States, about 10% of patients fail to take prescribed drugs, largely because of cost. "This is reducing their chances of survival," they point out (Chustecka, 5/1).

This is part of Kaiser Health News' Daily Report - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Report here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.